- AcelRx Pharmaceuticals (NASDAQ:ACRX) prices its public offering of 12,698,412 shares of common stock, at a price of $3.15 per share, for gross proceeds of ~$40M.
- Underwriters over-allotment is an additional 1,904,761 shares.
- Net proceeds will be used to fund the commercial launch of DSUVIA and for general corporate purposes.
- Closing date is November 14.
- Previously: AcelRx Pharma readies stock offering; shares down 14% premarket (Nov. 9)
AcelRx Pharmaceuticals prices public offering of common stock
Recommended For You
About TLPH Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
TLPH | - | - |
Talphera, Inc. |